Global Oncolytic Virus Therapy Market Growth (Status and Outlook) 2023-2029

Global Oncolytic Virus Therapy Market Growth (Status and Outlook) 2023-2029

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
LPI (LP Information)' newest research report, the “Oncolytic Virus Therapy Industry Forecast” looks at past sales and reviews total world Oncolytic Virus Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Therapy sales for 2023 through 2029. With Oncolytic Virus Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Therapy industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncolytic Virus Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Therapy.
The global Oncolytic Virus Therapy market size is projected to grow from US$ 6 million in 2022 to US$ 29 million in 2029; it is expected to grow at a CAGR of 25.8% from 2023 to 2029.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Segmentation by application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Please note: The report will take approximately 2 business days to prepare and deliver.